dorsaVi Past Earnings Performance

Past criteria checks 0/6

dorsaVi has been growing earnings at an average annual rate of 35.5%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been declining at an average rate of 8.1% per year.

Key information

35.5%

Earnings growth rate

52.7%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate-8.1%
Return on equity-121.9%
Net Margin-95.8%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Here's Why dorsaVi Ltd's (ASX:DVL) CEO Compensation Is The Least Of Shareholders Concerns

Nov 23
Here's Why dorsaVi Ltd's (ASX:DVL) CEO Compensation Is The Least Of Shareholders Concerns

A Look At dorsaVi's (ASX:DVL) CEO Remuneration

Jan 03
A Look At dorsaVi's (ASX:DVL) CEO Remuneration

Revenue & Expenses Breakdown

How dorsaVi makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:DVL Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241-130
31 Mar 241-130
31 Dec 231-230
30 Sep 232-230
30 Jun 232-230
31 Mar 232-240
31 Dec 222-240
30 Sep 222-240
30 Jun 222-240
31 Mar 222-250
31 Dec 212-350
30 Sep 212-340
30 Jun 212-240
31 Mar 212-240
31 Dec 202-240
30 Sep 202-540
30 Jun 202-840
31 Mar 202-850
31 Dec 192-850
30 Sep 192-650
30 Jun 193-460
31 Mar 193-460
31 Dec 183-460
30 Sep 183-460
30 Jun 183-470
31 Mar 184-470
31 Dec 174-570
30 Sep 174-470
30 Jun 173-460
31 Mar 173-460
31 Dec 163-360
30 Sep 163-470
30 Jun 163-570
31 Mar 163-680
31 Dec 152-780
30 Sep 152-880
30 Jun 151-890
31 Mar 151-780
31 Dec 141-670
30 Sep 141-560
30 Jun 141-440
31 Mar 141-330

Quality Earnings: DVL is currently unprofitable.

Growing Profit Margin: DVL is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DVL is unprofitable, but has reduced losses over the past 5 years at a rate of 35.5% per year.

Accelerating Growth: Unable to compare DVL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DVL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).


Return on Equity

High ROE: DVL has a negative Return on Equity (-121.91%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 20:22
End of Day Share Price 2025/01/02 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

dorsaVi Ltd is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterBell Potter
Matthijs SmithCanaccord Genuity
Matthijs SmithCanaccord Genuity (Australia)